SCREENING WITH PROSTATE SPECIFIC ANTIGEN AND METASTATIC PROSTATE CANCER RISK: A POPULATION BASED CASE-CONTROL STUDY

In this case-control study screening of asymptomatic men with PSA was associated with a significantly reduced risk of metastatic prostate cancer. The results need to be confirmed in randomized controlled trials.